Pages that link to "Q34343172"

The following pages link to Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review (Q34343172):

Displaying 37 items.

• Vitamin D in the cancer patient (Q27006469) (← links)
• Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells (Q27314983) (← links)
• Animal models of peripheral neuropathy due to environmental toxicants (Q28394003) (← links)
• Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia (Q33952803) (← links)
• Targeting DNA repair pathways for cancer treatment: what's new? (Q34015040) (← links)
• Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer (Q35002187) (← links)
• Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review (Q35596252) (← links)
• Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer (Q35903161) (← links)
• Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale (Q36117942) (← links)
• Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial (Q36350645) (← links)
• Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies (Q37168753) (← links)
• Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX (Q37244795) (← links)
• Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy (Q37541146) (← links)
• Chemotherapy induced peripheral neuropathic pain (Q38237393) (← links)
• Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. (Q38254351) (← links)
• A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. (Q38582633) (← links)
• Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy. (Q38719679) (← links)
• Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance). (Q38722948) (← links)
• Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review (Q38993256) (← links)
• Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress (Q39166397) (← links)
• Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial (Q39289330) (← links)
• A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). (Q39406087) (← links)
• Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms. (Q48106419) (← links)
• Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy. (Q50237975) (← links)
• Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial (Q50250068) (← links)
• Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer (Q50560002) (← links)
• Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source. (Q52693014) (← links)
• Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. (Q53549443) (← links)
• A Systematic Review of Herbal Medicine for Chemotherapy Induced Peripheral Neuropathy. (Q55334538) (← links)
• Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data (Q57181016) (← links)
• Neuroprotective Role of Selected Antioxidant Agents in Preventing Cisplatin-Induced Damage of Human Neurons In Vitro. (Q64938427) (← links)
• Maree Colosimo (Q71008006) (← links)
• Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathy (Q89813324) (← links)
• Recent advances in understanding chemotherapy-induced peripheral neuropathy (Q90577394) (← links)
• Insights into platinum-induced peripheral neuropathy-current perspective (Q90630289) (← links)
• Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance) (Q91702131) (← links)
• The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma (Q92197112) (← links)